Premium
In vitro effectiveness of 13 agents in otomycosis and review of the literature
Author(s) -
Stern Jordan C.,
Lucente Frank E.,
Shah Mahendra K.
Publication year - 1988
Publication title -
the laryngoscope
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.181
H-Index - 148
eISSN - 1531-4995
pISSN - 0023-852X
DOI - 10.1288/00005537-198811000-00005
Subject(s) - clotrimazole , natamycin , medicine , nystatin , miconazole , amphotericin b , dermatology , antifungal , pharmacology , fluconazole , microbiology and biotechnology , biology , pathology
Many agents have been recommended for treating otomycosis, but no preparation has been widely accepted. To compare the effectiveness of many recommended preparations, we performed an in vitro study using 15 species of fungi and yeast cultured from patients presenting with otomycosis during the past year. By measuring zones of inhibition, we assessed the effectiveness of aqueous Merthiolate®, Burow's solution (2%), VoSol® HC, VoSol® plain, Cortisporin® suspension, clotrimazole 1%, Mycostatin®, amphotericin B, ethanol 95%, miconazole, tolnaftate 1%, natamycin, and flucytosine. Most otic preparations showed little or no growth inhibition. However, Merthiolate® was very effective against all organisms tested, clotrimazole was very effective against most yeast and fungi tested, and nystatin had the widest spectrum of activity among the antifungals. Tolnaftate was ineffective. Vigorous cleaning of the external auditory canal remains the mainstay in treating otymycosis, but proper laboratory identification and suitable topical therapy are also important in dealing with this capricious infection.